Innovative breast cancer detection using a segmentation-guided ensemble classification framework.

IF 3.2 4区 医学 Q2 ENGINEERING, BIOMEDICAL
Biomedical Engineering Letters Pub Date : 2024-10-18 eCollection Date: 2025-01-01 DOI:10.1007/s13534-024-00435-7
P Manju Bala, U Palani
{"title":"Innovative breast cancer detection using a segmentation-guided ensemble classification framework.","authors":"P Manju Bala, U Palani","doi":"10.1007/s13534-024-00435-7","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer (BC) remains a significant global health issue, necessitating innovative methodologies to improve early detection and diagnosis. Despite the existence of intelligent deep learning models, their efficacy is often limited due to the oversight of small-sized masses, leading to false positive and false negative outcomes. This research introduces a novel segmentation-guided classification model developed to increase BC detection accuracy. The designed model unfolds in two critical phases, each contributing to a comprehensive BC diagnostic pipeline. In Phase I, the Attention U-Net model is utilized for BC segmentation. The encoder extracts hierarchical features, while the decoder, supported by attention mechanisms, refines the segmentation, focusing on suspicious regions. In Phase II, a novel ensemble approach is introduced for BC classification, involving various feature extraction methods, base classifiers, and a meta-classifier. An ensemble of model classifiers-including support vector machine, decision trees, k-nearest neighbor and artificial neural network- captures diverse patterns within these features. The Random Forest meta-classifier amalgamates their outputs, leveraging their collective strengths. The proposed integrated model accurately identifies different breast tumor classes, including malignant, benign, and normal. The precise region-of-interest analysis from segmentation phase significantly boosted classification performance of ensemble meta-classifier. The model accomplished an overall accuracy rate of 99.57% with high segmentation performance of 95% f1-score, illustrating its high discriminative power in detecting malignant, benign, and normal cases within the ultrasound image dataset. This research contributes to reducing breast tumor morbidity and mortality by facilitating early detection and timely intervention, ultimately supporting better patient outcomes.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13534-024-00435-7.</p>","PeriodicalId":46898,"journal":{"name":"Biomedical Engineering Letters","volume":"15 1","pages":"179-191"},"PeriodicalIF":3.2000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704121/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Engineering Letters","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s13534-024-00435-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Breast cancer (BC) remains a significant global health issue, necessitating innovative methodologies to improve early detection and diagnosis. Despite the existence of intelligent deep learning models, their efficacy is often limited due to the oversight of small-sized masses, leading to false positive and false negative outcomes. This research introduces a novel segmentation-guided classification model developed to increase BC detection accuracy. The designed model unfolds in two critical phases, each contributing to a comprehensive BC diagnostic pipeline. In Phase I, the Attention U-Net model is utilized for BC segmentation. The encoder extracts hierarchical features, while the decoder, supported by attention mechanisms, refines the segmentation, focusing on suspicious regions. In Phase II, a novel ensemble approach is introduced for BC classification, involving various feature extraction methods, base classifiers, and a meta-classifier. An ensemble of model classifiers-including support vector machine, decision trees, k-nearest neighbor and artificial neural network- captures diverse patterns within these features. The Random Forest meta-classifier amalgamates their outputs, leveraging their collective strengths. The proposed integrated model accurately identifies different breast tumor classes, including malignant, benign, and normal. The precise region-of-interest analysis from segmentation phase significantly boosted classification performance of ensemble meta-classifier. The model accomplished an overall accuracy rate of 99.57% with high segmentation performance of 95% f1-score, illustrating its high discriminative power in detecting malignant, benign, and normal cases within the ultrasound image dataset. This research contributes to reducing breast tumor morbidity and mortality by facilitating early detection and timely intervention, ultimately supporting better patient outcomes.

Supplementary information: The online version contains supplementary material available at 10.1007/s13534-024-00435-7.

使用分段引导的集成分类框架的创新乳腺癌检测。
乳腺癌仍然是一个重大的全球健康问题,需要创新方法来改进早期发现和诊断。尽管存在智能深度学习模型,但由于对小规模群众的监督,其功效往往受到限制,导致假阳性和假阴性结果。本研究提出了一种新的以分割为导向的分类模型,以提高BC的检测精度。设计的模型分为两个关键阶段,每个阶段都有助于全面的BC诊断管道。在第一阶段,使用注意力U-Net模型进行BC分割。编码器提取层次特征,而解码器在注意机制的支持下,对可疑区域进行细化分割。在第二阶段,引入了一种新的集成方法用于BC分类,包括各种特征提取方法、基分类器和元分类器。模型分类器的集合——包括支持向量机、决策树、k近邻和人工神经网络——捕捉这些特征中的不同模式。随机森林元分类器合并它们的输出,利用它们的集体优势。所提出的综合模型能够准确识别乳腺肿瘤的不同类型,包括恶性、良性和正常。从切分阶段进行精确的兴趣区域分析,显著提高了集成元分类器的分类性能。该模型总体准确率达到99.57%,分割性能达到95% f1-score,说明该模型在超声图像数据集中对恶性、良性和正常病例的检测具有较高的判别能力。该研究有助于通过促进早期发现和及时干预来降低乳腺肿瘤的发病率和死亡率,最终支持更好的患者预后。补充信息:在线版本包含补充资料,下载地址:10.1007/s13534-024-00435-7。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biomedical Engineering Letters
Biomedical Engineering Letters ENGINEERING, BIOMEDICAL-
CiteScore
6.80
自引率
0.00%
发文量
34
期刊介绍: Biomedical Engineering Letters (BMEL) aims to present the innovative experimental science and technological development in the biomedical field as well as clinical application of new development. The article must contain original biomedical engineering content, defined as development, theoretical analysis, and evaluation/validation of a new technique. BMEL publishes the following types of papers: original articles, review articles, editorials, and letters to the editor. All the papers are reviewed in single-blind fashion.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信